Maynard Um
-
-
-
-
-
-
-
Abivax (ABVX) PT Raised to $150 at BTIG
-
-
-
-
-
-
-
Barclays Starts Abivax (ABVX) at Overweight
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)
-
-
-
-
-
-
-
Abivax (ABVX) PT Raised to $101 at Guggenheim
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Abivax (ABVX), PT $50
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Abivax (ABVX) Following New IBD Surveys
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Abivax (ABVX)
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

